Start Date: 10/3/2024 6:30 PM CDT
End Date: 10/3/2024 7:30 PM CDT
Location:
United States
Event Website: https://forms.office.com/Pages/ResponsePage.aspx?id=vdf-_WqfoUS2lG45xGjBUADolgvDtbBCoSWvSaQsV1FUQlMxWkc2TzlVRlJDODU1Tk05WUJHVk4yMS4u
Organization Name:
Nebraska Pharmacists Association
Contact:
.png)
Join us at The Lodge at Wilderness Ridge in Lincoln, Nebraska, on October 3, 2024, at 6:30 pm (CST) for an insightful presentation on Cardiovascular Risk Reduction in Persons with Overweight or Obesity: The SELECT Trial. Speaker Dr. Libby Orzel, a cardiovascular specialist and Medical Science Liaison with Novo Nordisk will discuss how body weight affects cardiovascular disease and share the latest treatment options for reducing cardiovascular risk in patients with overweight or obesity. Don’t miss this opportunity to enhance your expertise and hear from an industry leader in cardiometabolic care. This live event is open to members and non-members. Space is limited. Register early!
